Public-registry trials using ADP101 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Open-label Extension Study of ADP101 | Alladapt Immunotherapeutics, Inc. | Food Allergy | PHASE1 / PHASE2 | 14 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →